ESR1 and breast carcinoma: Given the emerging data for the role of the RS, as well as the recent discrepant guidelines, we sought to assess recent practice patterns to evaluate both the factors influencing RS testing and the impact of RS results on adjuvant chemotherapy recommendations in node positive, ER+/HER2− breast cancer patients using the National Cancer Database (NCDB).